{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:26:00Z","timestamp":1792106760518,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH177"],"award-info":[{"award-number":["ZR2022MH177"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110913","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:15:50Z","timestamp":1694819750000},"page":"110913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PB","title":["A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis"],"prefix":"10.1016","volume":"124","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qincheng","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-1443","authenticated-orcid":false,"given":"Qiang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.intimp.2023.110913_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110913_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.matbio.2016.07.008","article-title":"Basement membranes and autoimmune diseases","volume":"57\u201358","author":"Foster","year":"2017","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110913_b0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.49.9.665","article-title":"Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis","volume":"49","author":"Tetta","year":"1990","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/art.37853","article-title":"Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts","volume":"65","author":"Lee","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2023.110913_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565275","article-title":"Innate lymphocytes in inflammatory arthritis","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0022-2015","article-title":"Anti-TNF Therapy","volume":"4","author":"Udalova","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"10093","key":"10.1016\/j.intimp.2023.110913_b0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(17)31618-5","article-title":"Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b\/4, double-blind, head-to-head, randomised controlled trial","volume":"390","author":"Fleischmann","year":"2017","journal-title":"Lancet"},{"issue":"530","key":"10.1016\/j.intimp.2023.110913_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110913_b0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/1744666X.2015.1027151","article-title":"Iguratimod for the treatment of rheumatoid arthritis in Japan","volume":"11","author":"Tanaka","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/PL00000291","article-title":"An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation","volume":"51","author":"Aikawa","year":"2002","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2457","article-title":"The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis","volume":"10","author":"Brown","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110913_b0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.intimp.2016.03.038","article-title":"Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-kappaB and MAPK pathways","volume":"35","author":"Gan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110913_b0065","doi-asserted-by":"crossref","first-page":"4901591","DOI":"10.1155\/2018\/4901591","article-title":"T-614 promotes osteoblastic cell differentiation by increasing Dlx5 expression and regulating the activation of p38 and NF-kappaB","volume":"2018","author":"Song","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"3","key":"10.1016\/j.intimp.2023.110913_b0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/s10165-012-0724-8","article-title":"Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Ishiguro","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110913_b0075","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/acr.22303","volume":"66","author":"Iwamoto","year":"2014","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0080","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/14397595.2018.1486939","article-title":"The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab","volume":"29","author":"Ebina","year":"2019","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci"},{"issue":"7293","key":"10.1016\/j.intimp.2023.110913_b0090","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/rheumatology\/kem372","article-title":"Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project)","volume":"47","author":"Kastbom","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110913_b0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110913_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.intimp.2023.110913_b0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/icb.2013.15","article-title":"Regulation of TNF-alpha with a focus on rheumatoid arthritis","volume":"91","author":"Moelants","year":"2013","journal-title":"Immunol. Cell Biol."},{"issue":"16","key":"10.1016\/j.intimp.2023.110913_b0115","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1073\/pnas.89.16.7375","article-title":"Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice","volume":"89","author":"Thorbecke","year":"1992","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2023.110913_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107219","article-title":"Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-alpha signaling pathways","volume":"90","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110913_b0125","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar2554","article-title":"T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis","volume":"10","author":"Du","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.110913_b0130","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.3892\/mmr.2017.7648","article-title":"Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-gamma","volume":"16","author":"Wu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2023.110913_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.809806","article-title":"Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2023.110913_b0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.41963","article-title":"Attenuation of rheumatoid arthritis through the inhibition of tumor necrosis factor-induced caspase 3\/gasdermin E-mediated pyroptosis","volume":"74","author":"Zhai","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110913_b0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11427-020-1939-1","article-title":"Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-kappaB signaling pathway","volume":"65","author":"Ge","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110913_b0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.12667","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110913_b0155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.110913_b0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41374-018-0135-3","article-title":"The role of Ca(2+) in acid-sensing ion channel 1a-mediated chondrocyte pyroptosis in rat adjuvant arthritis","volume":"99","author":"Wu","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2023.110913_b0165","doi-asserted-by":"crossref","first-page":"4566851","DOI":"10.1155\/2022\/4566851","article-title":"The ROS\/GRK2\/HIF-1alpha\/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes and the regulation of monomer derivatives of paeoniflorin","volume":"2022","author":"Hong","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.intimp.2023.110913_b0170","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jbspin.2015.10.007","article-title":"MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytes","volume":"83","author":"Li","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2023.110913_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.852802","article-title":"Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients","volume":"13","author":"Vomero","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:04:31Z","timestamp":1761588271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923012389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"alternative-id":["S1567576923012389"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110913","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110913"}}